Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Asthma management with HFA-BDP (Qvar).

R Davies1, C Leach, B Lipworth

  • 1London Chest Hospital.

Hospital Medicine (London, England : 1998)
|July 9, 1999
PubMed
Summary

Hydrofluoroalkane-beclomethasone dipropionate (HFA-BDP) offers asthma management benefits. This inhaled corticosteroid provides similar efficacy and safety to older formulations but at a reduced dosage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Operando neutron diffraction reveals mechanisms for controlled strain evolution in 3D printing.

Nature communications·2023
Same author

A 'provocative' MRI: the detective in ambiguous groin symptoms?

Hernia : the journal of hernias and abdominal wall surgery·2023
Same author

Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis.

Allergy·2023
Same author

The Rise of Supportive Oncology: A Revolution in Cancer Care.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

Suppression of black-hole growth by strong outflows at redshifts 5.8-6.6.

Nature·2022
Same author

Drivers of ecological assembly in the hindgut of Atlantic Cod fed a macroalgal supplemented diet.

NPJ biofilms and microbiomes·2022

Area of Science:

  • Pulmonology
  • Pharmacology
  • Clinical Trials

Background:

  • Asthma management relies on inhaled corticosteroids.
  • Chlorofluorocarbon-beclomethasone dipropionate (CFC-BDP) has been a standard treatment.
  • Development of alternatives with improved safety and efficacy profiles is ongoing.

Purpose of the Study:

  • To review the role of hydrofluoroalkane-beclomethasone dipropionate (HFA-BDP) in asthma management.
  • To evaluate pharmacokinetic, efficacy, and safety data of HFA-BDP.
  • To compare HFA-BDP with CFC-BDP.

Main Methods:

  • Review of clinical trial data.
  • Pharmacokinetic studies.
  • Efficacy and safety assessments.

Main Results:

  • HFA-BDP demonstrates equivalent efficacy to CFC-BDP.
  • HFA-BDP shows comparable safety profile to CFC-BDP.
  • HFA-BDP achieves therapeutic effects at approximately half the dose of CFC-BDP.

Conclusions:

  • HFA-BDP is an effective and safe alternative for asthma management.
  • The reduced dosage of HFA-BDP offers potential advantages.
  • HFA-BDP represents an advancement in inhaled corticosteroid therapy for asthma.

Related Experiment Videos